Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Taneja

Showing results (331-340 of 845) with videos related to

Pageof 85
Sort By:
The Journal of Urology|January 15, 2013
Re: screening for prostate cancer with prostate-specific antigen testing: american society of clinical oncology provisional clinical opinionSamir S Taneja
The Journal of Urology|January 15, 2013
Re: long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trialSamir S Taneja
The Journal of Urology|January 15, 2013
Re: association between germline HOXB13 G84E mutation and risk of prostate cancerSamir S Taneja
The Journal of Urology|December 14, 2012
Re: Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal massesSamir S Taneja
The Journal of Urology|December 14, 2012
Re: A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancerSamir S Taneja
The Journal of Urology|May 15, 2012
Re: Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinomaSamir S Taneja
The Journal of Urology|February 12, 2013
Re: impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysisSamir S Taneja
The Journal of Urology|April 19, 2013
Re: A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the cancer and osteoporosis research with alendronate and leuprolide (CORAL) studySamir S Taneja
The Journal of Urology|April 19, 2013
Re: dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: results from the randomised, placebo-controlled avodart after radical therapy for prostate cancer study (ARTS)Samir S Taneja
The Journal of Urology|May 14, 2013
Re: 11C-choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomySamir S Taneja
Pageof 85

Showing results (331-340 of 845) with videos related to

Sort By:
Pageof 85
The Journal of Urology|January 15, 2013
Re: screening for prostate cancer with prostate-specific antigen testing: american society of clinical oncology provisional clinical opinionSamir S Taneja
The Journal of Urology|January 15, 2013
Re: long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trialSamir S Taneja
The Journal of Urology|January 15, 2013
Re: association between germline HOXB13 G84E mutation and risk of prostate cancerSamir S Taneja
The Journal of Urology|December 14, 2012
Re: Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal massesSamir S Taneja
The Journal of Urology|December 14, 2012
Re: A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancerSamir S Taneja
The Journal of Urology|May 15, 2012
Re: Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinomaSamir S Taneja
The Journal of Urology|February 12, 2013
Re: impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysisSamir S Taneja
The Journal of Urology|April 19, 2013
Re: A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the cancer and osteoporosis research with alendronate and leuprolide (CORAL) studySamir S Taneja
The Journal of Urology|April 19, 2013
Re: dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: results from the randomised, placebo-controlled avodart after radical therapy for prostate cancer study (ARTS)Samir S Taneja
The Journal of Urology|May 14, 2013
Re: 11C-choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomySamir S Taneja
Pageof 85